SCHEMBL1035993

SCHEMBL1035993

COc1ccc(-c2cc3ccccc3c(=O)n2Cc2ccccc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.53
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
GAA P10253 2/20 0.53
RECQL P46063 1/20 0.53
TDP1 Q9NUW8 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
KDM4E B2RXH2 3/20 0.50
HPGD P15428 3/20 0.50
MAPT P10636 3/20 0.50
HTT P42858 2/20 0.50
P2RX4 Q99571 1/20 0.50
NPSR1 Q6W5P4 2/20 0.49
ADORA3 P0DMS8 1/20 0.48
MAPK8 P45983 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
TP53 P04637 1/20 0.48
BLM P54132 1/20 0.47
POLB P06746 1/20 0.47
EDNRB P24530 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2428892 0.95 TDP1 (0.54) ALDH1A1MEN1KMT2AGAARECQL
SCHEMBL1033233 0.89 F11 (0.45) ALDH1A1MEN1KMT2AGAARECQL
SCHEMBL1034613 0.87 ALDH1A1 (0.56) ALDH1A1MEN1KMT2AGAARECQL
SCHEMBL1030620 0.83 ALDH1A1 (0.51) ALDH1A1MEN1KMT2AGAATDP1
SCHEMBL1032777 0.83 MEN1 (0.50) ALDH1A1MEN1KMT2AGAARECQL
SCHEMBL1032985 0.82 ALDH1A1 (0.49) ALDH1A1MEN1KMT2ATDP1KDM4E
SCHEMBL31014731 0.81 TDP1 (0.57) ALDH1A1MEN1KMT2AGAATDP1
SCHEMBL1033487 0.81 ALDH1A1 (0.55) ALDH1A1MEN1KMT2AGAARECQL
SCHEMBL1031735 0.79 TSHR (0.53) MEN1KMT2AGAATDP1KDM4E
SCHEMBL1033948 0.79 ALDH1A1 (0.48) ALDH1A1MEN1KMT2AGAARECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1572660-B1 ISOQUINOLINONE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS X CEPTOR THERAPEUTICS INC (US) 2011-01-26 EP disclosed
US-20080132521-A1 Isoquinolinone Derivatives and Their Use As Therapeutic Agents EXELIXIS, INC. (US) 2008-06-05 US disclosed
US-7265131-B2 Isoquinolinone derivatives and their use as therapeutic agents EXELIXIS, INC. (US) 2007-09-04 US disclosed
US-20040204447-A1 Isoquinolinone derivatives and their use as therapeutic agents X-CEPTOR THERAPEUTICS INC. 2004-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080132521-A1 Isoquinolinone Derivatives and Their Use As Therapeutic Agents NR1H2, NR1H3, NR1I2 ALDH1A1 601/4885MEN1 4349/4885KMT2A 3097/4885
US-20040204447-A1 Isoquinolinone derivatives and their use as therapeutic agents NR1H2, NR1I2, NR1H3 ALDH1A1 415/4885MEN1 4476/4885KMT2A 3367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.